326 related articles for article (PubMed ID: 25303976)
1. Role of mesenchymal cells in the natural history of ovarian cancer: a review.
Touboul C; Vidal F; Pasquier J; Lis R; Rafii A
J Transl Med; 2014 Oct; 12():271. PubMed ID: 25303976
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal cell interaction with ovarian cancer cells induces a background dependent pro-metastatic transcriptomic profile.
Lis R; Touboul C; Halabi NM; Madduri AS; Querleu D; Mezey J; Malek JA; Suhre K; Rafii A
J Transl Med; 2014 Mar; 12():59. PubMed ID: 24597747
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal cell interaction with ovarian cancer cells triggers pro-metastatic properties.
Lis R; Touboul C; Raynaud CM; Malek JA; Suhre K; Mirshahi M; Rafii A
PLoS One; 2012; 7(5):e38340. PubMed ID: 22666502
[TBL] [Abstract][Full Text] [Related]
4. Adipose-derived stem cells in ovarian cancer progression, metastasis, and chemoresistance.
Zhang W; Torres-Rojas C; Yue J; Zhu BM
Exp Biol Med (Maywood); 2021 Aug; 246(16):1810-1815. PubMed ID: 34229470
[TBL] [Abstract][Full Text] [Related]
5. The metastatic phenotype shift toward myofibroblast of adipose-derived mesenchymal stem cells promotes ovarian cancer progression.
Tang H; Chu Y; Huang Z; Cai J; Wang Z
Carcinogenesis; 2020 Apr; 41(2):182-193. PubMed ID: 31046126
[TBL] [Abstract][Full Text] [Related]
6. Cellular and molecular processes in ovarian cancer metastasis. A Review in the Theme: Cell and Molecular Processes in Cancer Metastasis.
Yeung TL; Leung CS; Yip KP; Au Yeung CL; Wong ST; Mok SC
Am J Physiol Cell Physiol; 2015 Oct; 309(7):C444-56. PubMed ID: 26224579
[TBL] [Abstract][Full Text] [Related]
7. Human carcinoma-associated mesenchymal stem cells promote ovarian cancer chemotherapy resistance via a BMP4/HH signaling loop.
Coffman LG; Choi YJ; McLean K; Allen BL; di Magliano MP; Buckanovich RJ
Oncotarget; 2016 Feb; 7(6):6916-32. PubMed ID: 26755648
[TBL] [Abstract][Full Text] [Related]
8. Isolation and characterization of tumor cells from the ascites of ovarian cancer patients: molecular phenotype of chemoresistant ovarian tumors.
Latifi A; Luwor RB; Bilandzic M; Nazaretian S; Stenvers K; Pyman J; Zhu H; Thompson EW; Quinn MA; Findlay JK; Ahmed N
PLoS One; 2012; 7(10):e46858. PubMed ID: 23056490
[TBL] [Abstract][Full Text] [Related]
9. An Ex Vivo Model of Ovarian Cancer Peritoneal Metastasis Using Human Omentum.
Wong T; Tedja R; Chehade H; Morris R; Alvero AB; Mor G
J Vis Exp; 2024 Jan; (203):. PubMed ID: 38345216
[TBL] [Abstract][Full Text] [Related]
10. Ovarian cancer stem cells: Molecular concepts and relevance as therapeutic targets.
Ahmed N; Abubaker K; Findlay JK
Mol Aspects Med; 2014 Oct; 39():110-25. PubMed ID: 23811037
[TBL] [Abstract][Full Text] [Related]
11. Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer.
Deng J; Wang L; Chen H; Hao J; Ni J; Chang L; Duan W; Graham P; Li Y
Oncotarget; 2016 Aug; 7(34):55771-55788. PubMed ID: 27304054
[TBL] [Abstract][Full Text] [Related]
12. CD44 variant 6 is correlated with peritoneal dissemination and poor prognosis in patients with advanced epithelial ovarian cancer.
Tjhay F; Motohara T; Tayama S; Narantuya D; Fujimoto K; Guo J; Sakaguchi I; Honda R; Tashiro H; Katabuchi H
Cancer Sci; 2015 Oct; 106(10):1421-8. PubMed ID: 26250934
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stem cells enhance ovarian cancer cell infiltration through IL6 secretion in an amniochorionic membrane based 3D model.
Touboul C; Lis R; Al Farsi H; Raynaud CM; Warfa M; Althawadi H; Mery E; Mirshahi M; Rafii A
J Transl Med; 2013 Jan; 11():28. PubMed ID: 23369187
[TBL] [Abstract][Full Text] [Related]
14. Surgical peritoneal stress creates a pro-metastatic niche promoting resistance to apoptosis via IL-8.
Pasquier J; Vidal F; Hoarau-Véchot J; Bonneau C; Daraï E; Touboul C; Rafii A
J Transl Med; 2018 Oct; 16(1):271. PubMed ID: 30285881
[TBL] [Abstract][Full Text] [Related]
15. Cancer stem cells, epithelial-mesenchymal transition, and drug resistance in high-grade ovarian serous carcinoma.
Chen X; Zhang J; Zhang Z; Li H; Cheng W; Liu J
Hum Pathol; 2013 Nov; 44(11):2373-84. PubMed ID: 23850493
[TBL] [Abstract][Full Text] [Related]
16. Ovarian cancer-associated mesothelial cells induce acquired platinum-resistance in peritoneal metastasis via the FN1/Akt signaling pathway.
Yoshihara M; Kajiyama H; Yokoi A; Sugiyama M; Koya Y; Yamakita Y; Liu W; Nakamura K; Moriyama Y; Yasui H; Suzuki S; Yamamoto Y; Ricciardelli C; Nawa A; Shibata K; Kikkawa F
Int J Cancer; 2020 Apr; 146(8):2268-2280. PubMed ID: 31904865
[TBL] [Abstract][Full Text] [Related]
17. Ovarian cancer microenvironment: implications for cancer dissemination and chemoresistance acquisition.
Thibault B; Castells M; Delord JP; Couderc B
Cancer Metastasis Rev; 2014 Mar; 33(1):17-39. PubMed ID: 24357056
[TBL] [Abstract][Full Text] [Related]
18. Ovarian cancer stem cells and their role in drug resistance.
Pieterse Z; Amaya-Padilla MA; Singomat T; Binju M; Madjid BD; Yu Y; Kaur P
Int J Biochem Cell Biol; 2019 Jan; 106():117-126. PubMed ID: 30508594
[TBL] [Abstract][Full Text] [Related]
19. Ovarian Cancer Stem Cells: Characterization and Role in Tumorigenesis.
Saha S; Parte S; Roy P; Kakar SS
Adv Exp Med Biol; 2021; 1330():151-169. PubMed ID: 34339036
[TBL] [Abstract][Full Text] [Related]
20. MiR-1180 from bone marrow-derived mesenchymal stem cells induces glycolysis and chemoresistance in ovarian cancer cells by upregulating the Wnt signaling pathway.
Gu ZW; He YF; Wang WJ; Tian Q; Di W
J Zhejiang Univ Sci B; 2019 Mar.; 20(3):219-237. PubMed ID: 30829010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
